The post Photo| Tehran: Life without Coronavirus appeared first on IRAN This Way.
]]>The Coronavirus headquarters also officially announced that it is not mandatory to use a mask outdoors.
Corona Covid-19 Statistics in IRAN
Iran was able to overcome the corona epidemic crisis by vaccinating 76% of the target population. Until July 11, 2022, according to the statistics, 64,647,488 people have injected the first dose of vaccine, 58,000,921 people have injected the second dose, and 27,754,172 people have injected the third dose of vaccine. Sinopharm, AstraZeneca, Sputnik V, PastoCovac, COVIran Barekat and Iranian-Australian Spikogen were the vaccines that were injected into people in Iran.
According to the official statistics of Iran’s Ministry of Health, 7,238,840 people have been infected with Corona and 141,390 people have died.
The post Photo| Tehran: Life without Coronavirus appeared first on IRAN This Way.
]]>The post Iranian-Australian Spikoge COVID-19 vaccine might gain license in Iran appeared first on IRAN This Way.
]]>Dr. Payam Tabarsi, infectious decease specialist, said in interview with IRNA on Saturday that authorization of Spikogen vaccine to be administered in Iran depends on being licensed by the Health Ministry.
And the current situation suggests that the vaccine would be authorized to be used, Dr. Tabarsi noted, adding that Spikogen’s manufacturer, CinnaGen company, has a capacity to produce 3 million doses a month.
He said that the vaccine has produced 77-percent immunity in its second phase of clinical test and the third phase would be completed by the end of September.
In the first and second phases of clinical test, respectively 16,800 and 2,500 people received the vaccine and 400 people have registered for the third phase, according to Dr. Tabarsi.
A joint production of Australia and Iran, Spikogen COVID-19 vaccine would be authorized in Iran for emergency use if its third phase clinical test is successful.
The vaccine has passed the pre-clinical and first phase of clinical test in Australia and confirmed by the Australian Health Ministry.
Iran’s Health Ministry also authorized the vaccine to continue with its second and third phases of clinical test in Iran.
The post Iranian-Australian Spikoge COVID-19 vaccine might gain license in Iran appeared first on IRAN This Way.
]]>The post Iran permited to use COV-Iran Barakat vaccine appeared first on IRAN This Way.
]]>Speaking to Iranian state TV on Sunday night, Health Minister Saeed Namaki issued an emergency permit to use COV-Iran Barakat in the current vaccination of the population.
He also said that the necessary permit to use Iran-Cuba jointly produced COVID vaccine will also be issued as early as next week.
The move comes amid reports of a shortage of vaccines in Iran as the vaccination of elderly aged above 60 is underway.
This is while, Jafar Sadegh Tabrizi, Director General for PHC Network Management at the Islamic Republic of Iran’s Ministry of Health said on Sunday that the country needs 120,000,000 doses of Covid-19 vaccines. He also said that a new shipment of vaccines containing a million doses will enter the country in the coming days.
Meanwhile, Head of Iran’s Food and Drug Administration (FDA), Dr. Mohammad-Reza Shanesaz, said Sunday the Iranian citizens who have been injected with a foreign-made coronavirus vaccine might be injected with an Iranian-made vaccine for their second dose. He assured that the Iranian and foreign-made vaccines are made in the same way and with the same quality.
The National Task Force for Fighting Coronavirus in Iran has announced that the second dose of Chinese vaccine will be distributed from Saturday and the second dose of Sputnik V will also be available.
Iranian Sputnik vaccine to be unveiled
Iran’s Health Minister Namaki informed that the Iranian version of the Sputnik Covid-19 vaccine will be unveiled on Sat.
Iranian Minister Masoud Namaki vowed that all Iranians will be vaccinated by the end of Autumn by domestically produced or imported vaccines.
The Spokesman of the Iran Food and Drug Administration (IFDA) said in mid-June that the Islamic Republic of Iran joined the club of manufacturers of coronavirus, COVID-19, vaccine.
In a tweet, Kianoush Jahanpour wrote, “Islamic Republic of Iran joined the coronavirus, COVID-19, vaccine manufacturers’ club by issuing a license for emergency use of COV-Iran Barakat; Iran, Russia, United States, China, UK, and India.”
Cuban Soberana 02 COVID-19 vaccine showing 62% efficiency
The Cuban biopharmaceutical corporation BioCubaFarma announced that the Soberana 02 vaccine against COVID-19 has an efficacy of over 60 percent.
“With only 2 doses, #Soberana02 reached 62% efficacy,” BioCubaFarma tweeted on Saturday.
Cuban President Miguel Diaz-Canel tweeted that the result has been confirmed by an independent committee with the Instituto Finlay de Vacunas, but the emergency use of the vaccine is yet to be approved by the Cuban regulatory agency CECMED, Sputnik reported.
“The efficacy of #Soberana02, in its two doses, exceeds the requirements of the World Health Organization for a vaccine candidate against #COVID19 to become an effective vaccine, which is 50%,” Diaz-Canel tweeted, adding that data on the three-shot Soberana Plus vaccine will be available soon.
Cuba has developed five promising vaccine candidates: Soberana 01, Soberana 02, Soberana Plus, Mambisa and Abdala. Over 4.3 million people have participated in trials of the Soberana 02 and Abdala vaccines, according to Cuba’s health ministry.
The post Iran permited to use COV-Iran Barakat vaccine appeared first on IRAN This Way.
]]>